Earnings Per Share

6 Months Ended

Jun. 30, 2025

Basic and diluted earnings (loss) per share is calculated based on the weighted-average number of shares outstanding in each period and dilutive stock options, unvested shares and warrants, to the extent such securities exist and have a dilutive effect on earnings (loss) per share. A reconciliation of the numerator and denominator of basic and diluted earnings (loss) per share follows (dollars in millions, except per share amounts; shares in thousands):


	Three Months Ended June 30,				Six Months Ended June 30,
	2025		2024		2025		2024

Numerator:
Net loss attributable to Surgery Partners, Inc.	$	(2.5)	$	(15.5)	$	(40.2)	$	(27.9)



Denominator:
Weighted average common shares outstanding:
Basic	126,980		126,134		126,792		126,053
Diluted (1)	126,980		126,134		126,792		126,053

Net loss per share attributable to common stockholders:
Basic	$	(0.02)	$	(0.12)	$	(0.32)	$	(0.22)
Diluted (1)	$	(0.02)	$	(0.12)	$	(0.32)	$	(0.22)

Dilutive securities outstanding not included in the computation of diluted loss per share as their effect is antidilutive:
Stock options	875		1,052		911		1,152
Restricted shares	183		110		208		154

(1)The impact of potentially dilutive securities for all periods was not considered because the effect would be anti-dilutive.